← Open Payments lookup

KATHRYN STEENSTRA: Open Payments

NPI 1265771372 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,292 in 29 payments from 13 companies in 2025. Trend: 2023 $385 · 2024 $465 · 2025 $1,292

Food & beverage: $1,292
CompanyPaymentsAmount
Janssen Biotech, Inc.7$454
E.R. Squibb & Sons, L.L.C.2$210
Legend Biotech USA Inc.6$156
Syndax Pharmaceuticals, Inc.1$113
JAZZ PHARMACEUTICALS INC.4$111
SANOFI-AVENTIS U.S. LLC2$74
Genmab U.S., Inc.1$33
Regeneron Healthcare Solutions, Inc.1$30
Takeda Pharmaceuticals U.S.A., Inc.1$26
Incyte Corporation1$24

Products named: RYBREVANT, CARVYKTI, REVUFORJ, REZUROCK, DEFITELIO, EPKINLY, RYLAZE, DARZALEX.

Industry payments across AZ — which companies pay providers there.